Machine learning‐enhanced noninvasive prenatal testing of monogenic disorders
- 30 April 2024
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 44 (9) , 1024-1032
Abstract
ObjectiveSingle-nucleotide variants (SNVs) are of great significance in prenatal diagnosis as they are the leading cause of inherited single-gene disorders (SGDs). Identifying SNVs in a non-invasive prenatal screening (NIPS) scenario is particularly challenging for maternally inherited SNVs. We present an improved method to predict inherited SNVs from maternal or paternal origin in a genome-wide manner.MethodsWe performed SNV-NIPS based on the combination of fragments of cell free DNA (cfDNA) features, Bayesian inference and a machine-learning (ML) prediction refinement step using random forest (RF) classifiers trained on millions of non-pathogenic variants. We next evaluate the real-world performance of our refined method in a clinical setting by testing our models on 16 families with singleton pregnancies and varying fetal fraction (FF) levels, and validate the results over millions of inherited variants in each fetus.ResultsThe average area under the ROC curve (AUC) values are 0.996 over all families for paternally inherited variants, 0.81 for the challenging maternally inherited variants, 0.86 for homozygous biallelic variants and 0.95 for compound heterozygous variants. Discriminative AUCs were achieved even in families with a low FF. We further investigate the performance of our method in correctly predicting SNVs in coding regions of clinically relevant genes and demonstrate significantly improved AUCs in these regions. Finally, we focus on the pathogenic variants in our cohort and show that our method correctly predicts if the fetus is unaffected or affected in all (10/10, 100%) of the families containing a pathogenic SNV.ConclusionsOverall, we demonstrate our ability to perform genome-wide NIPS for maternal and homozygous biallelic variants and showcase the utility of our method in a clinical setting. What is Already Known about This Topic?Current non-invasive prenatal screening (NIPS) methods have limitations in detecting maternally inherited single-nucleotide variants (SNVs) due to challenges in differentiating fetal and maternal cell-free DNA. Existing approaches for SNV detection in NIPS often focus on targeted genes or paternally inherited variants, leaving a gap in comprehensive genome-wide solutions, especially for challenging cases such as homozygous biallelic variants.What This Study Adds?This study presents an innovative method combining fragmentomic analysis, Bayesian inference, and machine learning, enabling accurate genome-wide prediction of both paternally and maternally inherited SNVs. It introduces a robust approach for detecting challenging cases, including maternally inherited and homozygous biallelic variants, in real-world clinical scenarios, enhancing the accuracy and scope of non-invasive prenatal screening.Keywords
This publication has 23 references indexed in Scilit:
- High-Resolution and Noninvasive Fetal Exome ScreeningNew England Journal of Medicine, 2023
- Non‐invasive fetal genotyping for maternal alleles with droplet digital PCR: A comparative study of analytical approachesPrenatal Diagnosis, 2023
- The use of deep learning towards dose optimization in low-dose computed tomography: A scoping reviewRadiography, 2022
- Clinical experience with non‐invasive prenatal screening for single‐gene disordersUltrasound in Obstetrics & Gynecology, 2021
- Improved noninvasive fetal variant calling using standardized benchmarking approachesComputational and Structural Biotechnology Journal, 2021
- Genome-wide noninvasive prenatal diagnosis of monogenic disorders: Current and future trendsComputational and Structural Biotechnology Journal, 2020
- Global distribution of consanguinity and their impact on complex diseases: Genetic disorders from an endogamous populationEgyptian Journal of Medical Human Genetics, 2017
- Cell-free DNAClinics In Laboratory Medicine, 2016
- Rate of de novo mutations and the importance of father’s age to disease riskNature, 2012
- Non-invasive prenatal measurement of the fetal genomeNature, 2012